|
|
|
|
Quintile for DII
|
Quintile for DII
|
Quintile for DII
|
Quintile for DII
|
Quintile for DII
|
|
|
|
Q1 |
Q1 |
Q2 |
Q3 |
Q4 |
Q5 |
|
Endometriosis |
Total, % (n) |
Most pro-inflammatory |
Most
pro-inflammatory |
|
|
|
Most anti inflammatory |
PTB <37 weeks |
|
|
|
|
|
|
|
|
aOR1 (95% CI) |
(-) |
4.5 (3844/84900) |
1 (Ref) |
1
(Ref) |
0.99 (0.89-1.10) |
0.99 (0.89-1.09) |
0.93 (0.83-1.03) |
1.03
(0.92-1.14) |
aOR1 (95% CI) |
(+) |
6.2 (202/3236) |
1 (Ref) |
1
(Ref) |
0.92 (0.56-1.52) |
0.84 (0.51-1.37) |
0.97 (0.60-1.57) |
0.80
(0.49-1.31) |
aOR2 (95% CI) |
(+) with ART |
7.8 (27/345) |
1 (Ref) |
1 (Ref) |
0.29 (0.06-1.38) |
0.26 (0.06-1.04) |
0.42 (0.12-1.49) |
0.82 (0.24-2.78) |
aOR2 (95% CI) |
(+) without ART |
6.1 (175/2891) |
1
(Ref) |
1 (Ref) |
1.05 (0.61-1.79) |
0.98 (0.57-1.67) |
1.07 (0.63-1.82) |
0.80 (0.47-1.39) |
PTB <34 weeks |
|
|
|
|
|
|
|
|
aOR1 (95% CI) |
(-) |
0.9 (786/84900) |
1 (Ref) |
1
(Ref) |
0.86 (0.69-1.07) |
0.77 (0.62-0.97) |
0.77 (0.61-0.96) |
0.80
(0.64-0.998) |
aOR1 (95% CI) |
(+) |
1.2 (38/3236) |
1 (Ref) |
1
(Ref) |
0.53 (0.20-1.42) |
0.37 (0.13-1.04) |
0.50 (0.19-1.30) |
0.35
(0.12-0.99) |
aOR2 (95% CI) |
(+) with ART |
1.4 (5/345) |
1 (Ref) |
1 (Ref) |
NA |
0.40 (0.02-7.14) |
0.39 (0.02-7.39) |
1.35
(0.11-17.1) |
aOR2 (95% CI) |
(+) without ART |
1.1 (33/2891) |
1
(Ref) |
1 (Ref) |
0.58 (0.21-1.59) |
0.35 (0.12-1.08) |
0.51 (0.18-1.41) |
0.25 (0.07-0.83) |
LBW <2500 g |
|
|
|
|
|
|
|
|
aOR1 (95% CI) |
(-) |
7.9 (6720/84873) |
1 (Ref) |
1
(Ref) |
0.98 (0.91-1.06) |
0.88 (0.81-0.95) |
0.88 (0.81-0.95) |
0.94
(0.86-1.01) |
aOR1 (95% CI) |
(+) |
10.0 (323/3238) |
1 (Ref) |
1
(Ref) |
0.95 (0.64-1.41) |
0.82 (0.55-1.21) |
0.96 (0.65-1.40) |
0.69
(0.46-1.04) |
aOR2 (95% CI) |
(+) with ART |
10.1 (35/345) |
1
(Ref) |
1 (Ref) |
0.82 (0.26-2.59) |
0.20 (0.06-0.71) |
0.38 (0.13-1.17) |
0.20 (0.05-0.84) |
aOR2 (95% CI) |
(+) without ART |
10.0 (288/2893) |
1
(Ref) |
1 (Ref) |
0.96 (0.63-1.46) |
0.93 (0.62-1.42) |
1.02 (0.67-1.54) |
0.78 (0.51-1.19) |
LBW <1500 g |
|
|
|
|
|
|
|
|
aOR1 (95% CI) |
(-) |
0.5 (453/84873) |
1 (Ref) |
1
(Ref) |
0.94 (0.70-1.25) |
0.83 (0.62-1.12) |
0.73 (0.54-0.99) |
0.88
(0.66-1.18) |
aOR1 (95% CI) |
(+) |
0.7 (24/3238) |
1 (Ref) |
1
(Ref) |
0.24 (0.06-0.91) |
0.27 (0.08-0.89) |
0.35 (0.11-1.07) |
0.13
(0.03-0.61) |
aOR2 (95% CI) |
(+) with ART |
0.6 (2/345) |
1 (Ref) |
1 (Ref) |
NA |
NA |
NA |
NA |
aOR2 (95% CI) |
(+) without ART |
0.8 (22/2893) |
1
(Ref) |
1 (Ref) |
0.27 (0.07-1.05) |
0.32 (0.09-1.10) |
0.41 (0.13-1.29) |
0.07 (0.01-0.60) |
HDP |
|
|
|
|
|
|
|
|
aOR1 (95% CI) |
(-) |
2.8 (2363/85149) |
1 (Ref) |
1
(Ref) |
0.90 (0.79-1.03) |
0.87 (0.77-0.995) |
0.85 (0.74-0.97) |
0.84
(0.73-0.95) |
aOR1 (95% CI) |
(+) |
3.2 (105/3249) |
1 (Ref) |
1
(Ref) |
0.52 (0.26-1.04) |
0.52 (0.27-1.00) |
0.79 (0.44-1.45) |
0.74
(0.40-1.35) |
aOR2 (95% CI) |
(+) with ART |
5.8 (20/347) |
1 (Ref) |
1 (Ref) |
0.90 (0.22-3.06) |
0.45 (0.11-1.86) |
0.68 (0.18-2.54) |
0.11 (0.01-1.02) |
aOR2 (95% CI) |
(+) without ART |
2.9 (85/2902) |
1
(Ref) |
1 (Ref) |
0.45 (0.20-1.02) |
0.53 (0.25-1.13) |
0.84 (0.43-1.66) |
0.91 (0.47-1.77) |